Last Updated: June 26, 2024
molecularresidualdisease.com has 4 NS records, 9 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for molecularresidualdisease.com are ns-246.awsdns-30.com, ns-1467.awsdns-55.org, ns-700.awsdns-23.net, ns-1860.awsdns-40.co.uk. A records for molecularresidualdisease.com are 52.218.246.18, 52.92.233.91, 52.218.181.194, 52.218.152.138, 52.92.165.147, 52.92.180.51, 52.92.184.131, 52.218.205.42, 52.92.209.107. We have observed molecularresidualdisease.com to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a AmazonS3 web server at 52.92.249.187 in United States. The website's description is: "signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it."
Search DigitalStakeout ASI to find another asset.
52.218.246.18
52.92.233.91
52.218.181.194
52.218.152.138
52.92.165.147
52.92.180.51
52.92.184.131
52.218.205.42
52.92.209.107
No DNS AAAA records
No DNS MX records
ns-246.awsdns-30.com
ns-1467.awsdns-55.org
ns-700.awsdns-23.net
ns-1860.awsdns-40.co.uk
No DNS TXT records
molecularresidualdisease.com has 1 subdomains in our inventory.
AmazonS3
52.92.249.187
United States
og:locale: en_us
og:type: article
og:title: signatera overview
og:description: signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it.
og:url: https://www.natera.com/oncology/signatera-advanced-cancer-detection/
og:site_name: natera
article:publisher: https://www.facebook.com/nateragenetics
article:modified_time: 2024-05-29t17:08:28+00:00
og:image: https://www.natera.com/wp-content/uploads/2022/08/icon-medicare.png
No certificate log entry found for molecularresidualdisease.com. Please check back at a later time.